「Polio」の版間の差分
ナビゲーションに移動
検索に移動
Vaccipedia.admin (トーク | 投稿記録) (ページの作成:「==poliovirus== *3 serotypes **wPV2 already eradicated in 2015 **wPV3 was declared to be eradicated in 17 October 2019 by WHO **wPV1 is still circulating in Pakistan and A…」) |
Vaccipedia.admin (トーク | 投稿記録) |
||
| (同じ利用者による、間の5版が非表示) | |||
| 1行目: | 1行目: | ||
| + | {{TM menu}} | ||
| + | |||
==poliovirus== | ==poliovirus== | ||
| + | *family ''Picornaviridae'', genus ''Enterovirus'' | ||
| + | **Human enterovirus A, B, C, D | ||
| + | ***PV belongs to HEV-C | ||
| + | ***EV71 belongs to HEV-A | ||
| + | ***EV68 (EV-D68) belongs to HEV-D | ||
| + | *non-enveloped single stranded positive sense RNA virus | ||
| + | **4 capsid proteins | ||
*3 serotypes | *3 serotypes | ||
**wPV2 already eradicated in 2015 | **wPV2 already eradicated in 2015 | ||
| 8行目: | 17行目: | ||
==VDPV== | ==VDPV== | ||
*cVDPV1 and cVDPV2 are endemic in Africa and Southeast Asia as well as in Pakistan and Afghanistan | *cVDPV1 and cVDPV2 are endemic in Africa and Southeast Asia as well as in Pakistan and Afghanistan | ||
| + | **in recent 12 months no local transmission in Southeast Asia | ||
*cVDPV3 is not identified so far | *cVDPV3 is not identified so far | ||
| + | |||
| + | *VDPV is relatively physically stable in environment but cannot keep infectivity not for long time, thus continuous detection of VDPV in enviromnent means continuous transmission and/or excretion of VDPV from people living in the community | ||
| + | *distribution of breech (disinfectant) and/or irradication ultraviolet light may be effective against PV/VDPV | ||
| + | *threshold of immunization coverage to maintain PV/VDPV free is 85-90% | ||
| + | |||
| + | ==Global Polio Eradication | ||
| + | *strategies | ||
| + | **extensive immunization with OPV or IPV | ||
| + | **surveillance of acute flaccid paralysis | ||
| + | **lab diagnosis | ||
| + | |||
| + | *AFP cases and true poliovirus infection overlap very little | ||
| + | **⇔Variola cases and true smallpox infection overlapped almost identically | ||
| + | |||
| + | |||
| + | *novel OPV2 | ||
| + | **using genetically modified stain | ||
| + | **more stabilized genomically | ||
| + | |||
| + | ==clinical== | ||
| + | *mostly asymptomatic | ||
| + | *many mild manifestation | ||
| + | *polio paralytic cases 79% by wPV1, 8% by wPV2, 13% by wPV3 in 2010 | ||
2021年5月30日 (日) 16:48時点における最新版
| Navigation Menu |
| General issues of Vaccine | |||||||
|---|---|---|---|---|---|---|---|
|
| General issues of Travel med. | ||||||||
|---|---|---|---|---|---|---|---|---|
|
| Immunology | |||||||
|---|---|---|---|---|---|---|---|
|
| Epi & Stats | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Virus | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| COVID-19 | |||||
|---|---|---|---|---|---|
|
| Bacteria | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Rickettsia | |||||
|---|---|---|---|---|---|
|
| Protozoa | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Fungi | |||||||
|---|---|---|---|---|---|---|---|
|
| Nematode (roundworm) | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Trematode (fluke, distoma) | |||||||
|---|---|---|---|---|---|---|---|
|
| Cestode (tapeworm) | ||||||
|---|---|---|---|---|---|---|
|
| Medical Zoology | ||||||||
|---|---|---|---|---|---|---|---|---|
|
poliovirus
- family Picornaviridae, genus Enterovirus
- Human enterovirus A, B, C, D
- PV belongs to HEV-C
- EV71 belongs to HEV-A
- EV68 (EV-D68) belongs to HEV-D
- Human enterovirus A, B, C, D
- non-enveloped single stranded positive sense RNA virus
- 4 capsid proteins
- 3 serotypes
- wPV2 already eradicated in 2015
- wPV3 was declared to be eradicated in 17 October 2019 by WHO
- wPV1 is still circulating in Pakistan and Afghanistan
- African region was certified as wild polio-free in 2020 by WHO
VDPV
- cVDPV1 and cVDPV2 are endemic in Africa and Southeast Asia as well as in Pakistan and Afghanistan
- in recent 12 months no local transmission in Southeast Asia
- cVDPV3 is not identified so far
- VDPV is relatively physically stable in environment but cannot keep infectivity not for long time, thus continuous detection of VDPV in enviromnent means continuous transmission and/or excretion of VDPV from people living in the community
- distribution of breech (disinfectant) and/or irradication ultraviolet light may be effective against PV/VDPV
- threshold of immunization coverage to maintain PV/VDPV free is 85-90%
==Global Polio Eradication
- strategies
- extensive immunization with OPV or IPV
- surveillance of acute flaccid paralysis
- lab diagnosis
- AFP cases and true poliovirus infection overlap very little
- ⇔Variola cases and true smallpox infection overlapped almost identically
- novel OPV2
- using genetically modified stain
- more stabilized genomically
clinical
- mostly asymptomatic
- many mild manifestation
- polio paralytic cases 79% by wPV1, 8% by wPV2, 13% by wPV3 in 2010